Featured Research

from universities, journals, and other organizations

Bionic bacteria may help make new drugs, biofuels: Artificially enhanced bacteria capable of producing new kinds of synthetic chemicals

Date:
September 22, 2011
Source:
Salk Institute
Summary:
A strain of genetically enhanced bacteria developed by researchers at the Salk Institute for Biological Studies may pave the way for new synthetic drugs and new ways of manufacturing medicines and biofuels, according to a new paper.

These bacterial smears show common E. coli strains that allow unnatural amino acid (Uaas) incorporation at one site only (left side), and an engineered strain that enables the incorporation of Uaas at multiple sites simultaneously (right side). The glow indicates the bacteria are producing full-length proteins with Uaas incorporated at different numbers of sites (as indicated by the surrounding numbers), a necessary step for their potential use in the production of new drugs and biofuels.
Credit: Image courtesy of Salk Institute for Biological Studies

A strain of genetically enhanced bacteria developed by researchers at the Salk Institute for Biological Studies may pave the way for new synthetic drugs and new ways of manufacturing medicines and biofuels, according to a paper published September 18 in Nature Chemical Biology.

For the first time, the scientists were able to create bacteria capable of effectively incorporating "unnatural" amino acids -- artificial additions to the 20 naturally occurring amino acids used as biological building blocks -- into proteins at multiple sites. This ability may provide a powerful new tool for the study of biological processes and for engineering bacteria that produce new types of synthetic chemicals.

"This provides us with a lot more room to think about what we can do with protein synthesis," said Lei Wang, assistant professor in Salk's Chemical Biology and Proteomics Laboratory and holder of the Frederick B. Rentschler Developmental Chair. "It opens up new possibilities, from creating drugs that last longer in the blood stream to manufacturing chemicals in a more environmentally friendly manner."

In 2001, Wang and his colleagues were the first to create bacteria that incorporated unnatural amino acids (Uaas) into proteins, and, in 2007, they first used the technique in mammalian cells. They did this by creating an "expanded genetic code," overriding the genetic code of the cells and instructing them to use the artificial amino acids in the construction of proteins.

The addition of Uaas changes the chemical properties of proteins, promising new ways to use proteins in research, drug development and chemical manufacturing.

For instance, Wang and his colleagues have inserted Uaas that will glow under a microscope when exposed to certain colors of light. Because proteins serve as the basis for a wide range of cellular functions, the ability to visualize this machinery operating in live cells and in real time helps scientists decipher a wide range of biological mechanisms, including those involved in the development of disease and aging.

Genetically modified bacteria are already used for producing medicines, such as synthetic insulin, which has largely replaced the use of animal pancreases in the manufacture of drugs used by diabetics to regulate their blood sugar levels.

To date, such recombinant DNA technology has used only natural amino acids, which limits the possible functions of the resulting protein products. The ability to insert Uaas could dramatically expand the possible uses of such technology, but one major barrier has limited the use of Uaas: only a single Uaa at a time could be incorporated into a protein.

To insert the instructions for including a Uaa in a bacterium's genetic code, Wang and his colleagues exploited stop codons, special sequences of code in a protein's genetic blueprint. During protein production, stop codons tell the cellular machinery to stop adding amino acids to the sequence that forms backbone of the protein's structure.

In 2001, Wang and his colleagues modified the genetic sequence of the bacteria Escherichia coli to selectively include a stop codon and introduced engineered molecules inside the bacteria, which surgically insert a Uaa at the stop codon. This trained the bacteria to produce proteins with the Uaa incorporated in their backbone.

The problem was that another biological actor, a protein known as release factor 1 (RF1), would stop the production of a Uaa-containing protein too early. Although scientists could insert stop codons for Uaas at multiple places along genetic sequence, the release factor would cut the protein off at the first stop codon, preventing production of long proteins containing multiple Uaas.

"To really make use of this technology, you want to be able to engineer proteins that contain unnatural amino acids at multiple sites, and to produce them in high efficiency," Wang said. "It was really promising, but, until now, really impractical."

In their new paper, the Salk researchers and their collaborators at the University of California, San Diego described how they got around this limitation. Since RF1 hindered production of long Uaa-containing proteins, the scientists removed the gene that produces RF1. Then, because E. Coli dies when the RF1 gene is deleted, they altered production of an alternative actor, release factor 2 (RF2), so that it could rescue the engineered bacterium.

The result was a strain of bacteria capable of efficiently producing proteins containing Uaas at multiple places. These synthetic molecules hold promise for the development of drugs with biological functions far beyond what is possible with proteins that include only naturally occurring amino acids. They may also serve as the basis for manufacturing everything from industrial solvents to biofuels, possibly helping to address the economic and environmental concerns associated with petroleum-based manufacturing and transportation.

"This is the first time we've been able to produce a viable strain of bacteria capable of this," Wang said. "We still have a ways to go, but this makes the possibility of using unnatural amino acids in biological engineering far closer to being reality."

The research was funded by the Beckman Young Investigator Program, the California Institute for Regenerative Medicine, the March of Dimes Foundation, the Mary K. Chapman Foundation, the National Institutes of Health, the National Science Foundation, the Pioneer Fellowship, the Ray Thomas Edwards Foundation and the Searle Scholar Program.


Story Source:

The above story is based on materials provided by Salk Institute. Note: Materials may be edited for content and length.


Journal Reference:

  1. David B F Johnson, Jianfeng Xu, Zhouxin Shen, Jeffrey K Takimoto, Matthew D Schultz, Robert J Schmitz, Zheng Xiang, Joseph R Ecker, Steven P Briggs, Lei Wang. RF1 knockout allows ribosomal incorporation of unnatural amino acids at multiple sites. Nature Chemical Biology, 2011; DOI: 10.1038/nchembio.657

Cite This Page:

Salk Institute. "Bionic bacteria may help make new drugs, biofuels: Artificially enhanced bacteria capable of producing new kinds of synthetic chemicals." ScienceDaily. ScienceDaily, 22 September 2011. <www.sciencedaily.com/releases/2011/09/110921172851.htm>.
Salk Institute. (2011, September 22). Bionic bacteria may help make new drugs, biofuels: Artificially enhanced bacteria capable of producing new kinds of synthetic chemicals. ScienceDaily. Retrieved October 21, 2014 from www.sciencedaily.com/releases/2011/09/110921172851.htm
Salk Institute. "Bionic bacteria may help make new drugs, biofuels: Artificially enhanced bacteria capable of producing new kinds of synthetic chemicals." ScienceDaily. www.sciencedaily.com/releases/2011/09/110921172851.htm (accessed October 21, 2014).

Share This



More Plants & Animals News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

'Cadaver Dog' Sniffs out Human Remains

'Cadaver Dog' Sniffs out Human Remains

AP (Oct. 21, 2014) Where's a body buried? Buster's nose can often tell you. He's a cadaver dog, specially trained to find human remains and increasingly being used by law enforcement and accepted in courts. These dogs are helping solve even decades-old mysteries. (Oct. 21) Video provided by AP
Powered by NewsLook.com
White Lion Cubs Born in Belgrade Zoo

White Lion Cubs Born in Belgrade Zoo

AFP (Oct. 20, 2014) Two white lion cubs, an extremely rare subspecies of the African lion, were recently born at Belgrade Zoo. They are being bottle fed by zoo keepers after they were rejected by their mother after birth. Duration: 00:42 Video provided by AFP
Powered by NewsLook.com
Traditional Farming Methods Gaining Ground in Mali

Traditional Farming Methods Gaining Ground in Mali

AFP (Oct. 20, 2014) He is leading a one man agricultural revolution in Mali - Oumar Diatabe uses traditional farming methods to get the most out of his land and is teaching others across the country how to do the same. Duration: 01:44 Video provided by AFP
Powered by NewsLook.com
Goliath Spider Will Give You Nightmares

Goliath Spider Will Give You Nightmares

Buzz60 (Oct. 20, 2014) An entomologist stumbled upon a South American Goliath Birdeater. With a name like that, you know it's a terrifying creepy crawler. Sean Dowling (@SeanDowlingTV) has the details. Video provided by Buzz60
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Plants & Animals

Earth & Climate

Fossils & Ruins

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins